Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin
NCT06103279
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Interventions
DRUG:
Empagliflozin 10 MG
Sponsor
Ain Shams University